Status:

UNKNOWN

PRP vs PRP+IVC for Severe nPDR

Lead Sponsor:

Ruijin Hospital

Collaborating Sponsors:

Shanghai Municipal Science and Technology Commission

Conditions:

Severe Nonproliferative Diabetic Retinopathy

Diabetic Retinopathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The randomized clinical trial aims to compare the therapeutic effects between panretinal photocoagulation(PRP) and PRP combined with intravitreal conbercept (IVC) injection in severe nPDR with/without...

Detailed Description

This was a prospective, randomized, two-armed study to assess the efficacy and safety of intravitreal conbercept injection plus PRP versus PRP in the treatment of nPDR patients with/without diabetic m...

Eligibility Criteria

Inclusion

  • Type II diabetic patients, 18 years and older, were included if the participants had:
  • severe non-PDR in either eyes with/without diabetic macular edema;
  • ETDRS letters-measured best-corrected visual acuity (BCVA) ranging from 20/40 to 20/320 Snellen equivalent;
  • no previous treatment (of any type) in either eye.

Exclusion

  • history of prior laser treatment or vitrectomy in the study eye;
  • history of thromboembolic event - including myocardial infarction or cerebral vascular accident;
  • major surgery within the prior 6 months or planned within the next 28 days;
  • history of glaucoma or ocular hypertension;
  • loss of vision as a result of other causes;
  • history of systemic corticosteroid therapy within the last 3 months;
  • severe systemic disease other than diabetes mellitus;
  • known coagulation abnormalities or current use of anticoagulative medication other than aspirin
  • any condition that could affect followup or documentation (including preretinal or vitreous hemorrhage).

Key Trial Info

Start Date :

January 18 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03863535

Start Date

January 18 2019

End Date

September 30 2021

Last Update

March 5 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ruijin Hospital

Shanghai, Shanghai Municipality, China, 20025